Table 3 Performance of the EPI test with a cut point of 15.6 in the pooled cohort.
EPI ≥ cut point | EPI < cut point | Total | Performance | (95%CI) | |
|---|---|---|---|---|---|
Biopsy positive/≥GG2 | 338 | 28 | 366 | Sensitivity, 92.3% | (89.1–94.9) |
Biopsy negative/GG1 | 591 | 255 | 846 | Specificity, 30.1% | (27.1–33.4) |
Total | 929 | 283 | 1212 | PPV, 36.4% | (33.3–39.6) |
NPV, 90.1% | (86.0–93.3) | ||||
Prevalence | 30.2% | Predicted negative | 23.3% |
